Loading…
Medicus Pharma Ltd. is projected to decline to $0.4013 by 2027, a -2% move from its current price of $0.4076. MDCX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.3841 | $0.4077 | $0.4328 | +0.03% |
| Jul 14 | $0.3748 | $0.4078 | $0.4437 | +0.05% |
| Jul 15 | $0.3679 | $0.4079 | $0.4523 | +0.08% |
| Jul 16 | $0.3621 | $0.408 | $0.4598 | +0.10% |
| Jul 17 | $0.3571 | $0.4081 | $0.4664 | +0.13% |
| Jul 18 | $0.3527 | $0.4082 | $0.4725 | +0.16% |
| Jul 19 | $0.3487 | $0.4083 | $0.4782 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3487 | $0.4083 | $0.4782 | +0.18% |
| Week 2 | $0.3272 | $0.4091 | $0.5114 | +0.36% |
| Week 3 | $0.3118 | $0.4098 | $0.5387 | +0.55% |
| Week 4 | $0.2994 | $0.4106 | $0.5631 | +0.73% |
| Week 5 | $0.2889 | $0.4113 | $0.5855 | +0.91% |
| Week 6 | $0.2799 | $0.4121 | $0.6067 | +1.09% |
| Week 7 | $0.2718 | $0.4128 | $0.6269 | +1.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome.
The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Medicus Pharma Ltd. (MDCX) is a healthcare stock with a current price of $0.4225 and a market cap of $23.94M, ranking 4853. The near-term outlook is reflected in a 30-day technical picture that remains NEUTRAL, with RSI14 at 50.
The stock’s shorter-term and longer-term moving averages show a bridge between the near and longer-term trendlines: the 50-day SMA sits at $0.3536 while the 200-day SMA is $1.22. Immediate support is $0.309 and resistance is $0.488. The 30-day price range extends from $0.2823 to $0.6324.
A major floor 41.8% below — a decisive break under it would weaken the trend.
The nearest floor, 21.5% below — buyers have tended to step in here.
The nearest ceiling, 19.7% above — a clean break opens room to run.
A major ceiling 260.6% above — clearing it would confirm fresh momentum.
Key MDCX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDCX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.432 | Sell | $0.4237 | Sell |
| MA 10 | $0.4368 | Sell | $0.426 | Sell |
| MA 20 | $0.4139 | Sell | $0.4125 | Sell |
| MA 50 | $0.3557 | Buy | $0.4163 | Sell |
| MA 100 | $0.4967 | Sell | $0.6067 | Sell |
| MA 200 | $1.20 | Sell | $1.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.72 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -9.56 | Neutral |
| Williams %R (14) | -90.91 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -10.33 | Sell |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 9.09 | Buy |
| TRIX (15) | 1.04 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 41.14 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 0.42 | Sell |
| ADX (14) | 14.69 | Neutral |
| ATR (14) | 0.02 | Info |
The near-term technical picture is NEUTRAL with RSI(14) at 50. The 50-day simple moving average is $0.3536 and the 200-day simple moving average is $1.22, illustrating a price position that is closer to the short-term average than the longer-term trend. Immediate support sits at $0.309 and resistance at $0.488, framing a near-term trading range from $0.2823 to $0.6324 over the last 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.275 | $0.4076 | $0.5408 | 0% | Neutral | |
| $0.2912 | $0.4013 | $0.598 | -2% | Neutral | |
| $0.3582 | $0.5246 | $0.8331 | +29% | Bullish | |
| $0.4232 | $0.6529 | $1.09 | +60% | Bullish | |
| $0.4146 | $0.6706 | $1.16 | +65% | Bullish | |
| $0.3527 | $0.5962 | $1.07 | +46% | Bullish | |
| $0.3456 | $0.6094 | $1.13 | +50% | Bullish | |
| $0.3157 | $0.5797 | $1.10 | +42% | Bullish | |
| $0.2884 | $0.551 | $1.08 | +35% | Bullish | |
| $0.3766 | $0.7478 | $1.49 | +83% | Bullish | |
| $0.3694 | $0.821 | $1.80 | +101% | Bullish | |
| $0.8404 | $1.87 | $4.30 | +358% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.275 | $0.4076 | $0.5177 | +0.00% |
| August 2026 | $0.3662 | $0.4436 | $0.5595 | +8.83% |
| September 2026 | $0.3397 | $0.4173 | $0.5375 | -5.91% |
| October 2026 | $0.3204 | $0.3984 | $0.5221 | -4.53% |
| November 2026 | $0.3301 | $0.4147 | $0.5514 | +4.09% |
| December 2026 | $0.3164 | $0.4014 | $0.5408 | -3.20% |
Click any year to see its month-by-month MDCX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MDCX could reach as high as $0.5408, with a base case around $0.4076 and support toward $0.275 — roughly 0% from $0.4076. A consolidation phase looks the most probable path here.
Expect MDCX to range from $0.2912 to $0.598 through 2027. The $0.4013 average target implies a -2% move from current prices. That is -2% versus the projected 2026 average. Price action looks broadly range-bound.
The MDCX price prediction for 2028 points to an average of $0.5246 (low $0.3582, high $0.8331) — a potential gain of +29% on today's $0.4076. Buyers look set to stay in control over this stretch.
In 2029, MDCX is projected to trade between $0.4232 and $1.09, averaging $0.6529 — a potential gain of +60% from today's $0.4076. That is up +24% on the projected 2028 average. Momentum favours further upside here.
Medicus Pharma Ltd.'s 2030 outlook centres on $0.6706, within a $0.4146 to $1.16 range. That is up +3% on the projected 2029 average. That marks a +65% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MDCX could reach as high as $1.07, with a base case around $0.5962 and support toward $0.3527 — roughly +46% from $0.4076. Momentum favours further upside here.
Expect MDCX to range from $0.3456 to $1.13 through 2032. The $0.6094 average target implies a +50% move from current prices. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The MDCX price prediction for 2033 points to an average of $0.5797 (low $0.3157, high $1.10) — a potential gain of +42% on today's $0.4076. Momentum favours further upside here.
In 2034, MDCX is projected to trade between $0.2884 and $1.08, averaging $0.551 — a potential gain of +35% from today's $0.4076. That is -5% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Medicus Pharma Ltd.'s 2035 outlook centres on $0.7478, within a $0.3766 to $1.49 range. That is up +36% on the projected 2034 average. That marks a +83% change versus current levels. Momentum favours further upside here.
By 2040, MDCX could reach as high as $1.80, with a base case around $0.821 and support toward $0.3694 — roughly +101% from $0.4076. Buyers look set to stay in control over this stretch.
Expect MDCX to range from $0.8404 to $4.30 through 2050. The $1.87 average target implies a +358% move from current prices. That is up +127% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MDCX today (≈ 2,453.385672 MDCX) could be worth
$4,581.67
+$3,581.67 (+358%) by 2050 · US Dollar
Based on the average projected MDCX price of $1.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDCXwould be worth at today's price.
$1,000 invested in MDCX on Jul 10, 2025 (≈ 303.030307 MDCX) would be worth
$123.52
-$876.48 (-87.6%) today · 0.12× · US Dollar
Based on a MDCX entry price of $3.3 vs. today's $0.4076.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.416 | $979.81 | -2.0% |
| 1 month ago | $0.32 | $1,273.75 | +27.4% |
| 3 months ago | $0.414 | $984.54 | -1.5% |
| 6 months ago | $1.46 | $279.18 | -72.1% |
| 1 year ago | $3.3 | $123.52 | -87.6% |
| All time (1.7y) ago | $2.65 | $153.81 | -84.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDCX forecast.
Our base-case forecast reaches $0.82 around 2040.
Implied market cap at $0.82: $46.46M
The multi-year forecast shows bullish momentum building after 2026, with 2026 at an average of $0.4225, a min of $0.275 and a max of $0.5581 (ROI 0, sentiment NEUTRAL). By 2028 the average is $0.5545 with a max of $0.8808 and a min of $0.3785 (ROI 31.2, sentiment BULLISH). The trajectory continues with 2029 average $0.6807, min $0.4411, max $1.14 (ROI 61.1, sentiment BULLISH) and 2030 average $0.6994, min $0.4323, max $1.21 (ROI 65.5, sentiment BULLISH).
Further years show ongoing upside, such as 2031 average $0.6258, 2032 average $0.6349, 2033 average $0.6077, 2034 average $0.5819, and 2035 average $0.7871 with a max of $1.57 (ROI 48.1%, 50.3%, 43.8%, 37.7%, 86.3% respectively and bullish sentiment). The forecast also projects 2040 average $0.8676 with a max of $1.90 (ROI 105.3, bullish) and 2050 average $1.96 with a max of $4.52 (ROI 365, bullish). These figures illustrate upside potential over the long horizon, but they are estimates rather than guarantees and come with the inherent uncertainty of biotech developments and market conditions.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $0.6994, with a minimum of $0.4323 and a maximum of $1.21, implying a 65.5% ROI and a bullish outlook.
The forecast points to bullish sentiment from 2028 onward, with an average price of $0.5545 in 2028 rising to $1.96 by 2050, a maximum of $4.52, and a 365% ROI by 2050. However, 2026–2027 are neutral and these are estimates, not guarantees.
Yes. The forecast shows the potential to reach $1 or more by years such as 2030 (max $1.21) and into later years, with 2035 max $1.57, 2040 max $1.90, and 2050 max $4.52.
For 2028 the forecast is min $0.3785, avg $0.5545, max $0.8808, with ROI 31.2% and a bullish sentiment.
The 2050 forecast shows min $0.8841, avg $1.96, max $4.52, with ROI 365% and bullish sentiment.
Medicus Pharma Ltd. Community Discussion
0Share your Medicus Pharma Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.